Charles Rosier - London Uk, Partner at btg pactual at Btg pactual
As a partner at BTG Pactual Bank, he got the opportunity to work with a popular institution with 30 years of experience, employing more than 2,500 workers in various locations in Latin America. GMS or Goldman Sachs is one of the best-known investment banks around the world. In his role as their Managing Director, he paid much mind to public asset management. From 1997 to 2009, Charles Rosier was the Debt Capital Manager of SBC Warburg. When he began his career as an investment banker, he went to work at Lehman Brothers.
Charles Rosier is involved in philanthropic and cultural activities. Great examples of this are his support for a Silver Lion-winning movie and a popular French artist. In 2006, he promoted a Silver Lion-winning film just before its production release, and he helped a French performer with her debut album in 2012. To express his love for culture and music, he extended his support to a French female singer. For Charles Rosier, culture and music are unparalleled. This is evident in the way he gives support to certain artists and movies.
To prepare himself for ESCP Europe, Charles Rosier took additional classes at a private school known as Integrale. It was in 1991 that he achieved his scientific degree at Fenelon Sainte-Marie. In 1996, Charles Rosier began his career at Lehman Brothers prior to joining UBS Warburg Investment Bank. A while later he joined Goldman Sachs Bank where he managed the finance department.
Charles Rosier and His Chosen Profession
In 1999, Goldman Sachs (GMS) offered Charles Rosier a new job opportunity. He became their Managing Director. Charles Rosier finally joined BTG Pactual in August 2010. BTG Pactual, an investment bank in Latin America, is a company at which Charles Rosier became a partner. As an outstanding investment banker, he has remained in the market for 15 years now.
Charles Rosier’s first healthcare project was the Mapreg Drug project. Charles Rosier invested in a pharmaceutical organisation (Mapreg) to develop a healthcare project, handled by Professor Etienne Baulieu. He also invested capital in the laboratory of Mapreg, located in Paris, to continue performing research about serious conditions including depression and stroke.